227 related articles for article (PubMed ID: 23712703)
21. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.
Park JS; Svetkauskaite D; He Q; Kim JY; Strassheim D; Ishizaka A; Abraham E
J Biol Chem; 2004 Feb; 279(9):7370-7. PubMed ID: 14660645
[TBL] [Abstract][Full Text] [Related]
22. Interaction effect between the receptor for advanced glycation end products (RAGE) and high-mobility group box-1 (HMGB-1) for the migration of a squamous cell carcinoma cell line.
Choi J; Lee MK; Oh KH; Kim YS; Choi HY; Baek SK; Jung KY; Woo JS; Lee SH; Kwon SY
Tumori; 2011; 97(2):196-202. PubMed ID: 21617715
[TBL] [Abstract][Full Text] [Related]
23. High-mobility group box 1 protein is implicated in advanced glycation end products-induced vascular endothelial growth factor A production in the rat retinal ganglion cell line RGC-5.
Lee JJ; Hsiao CC; Yang IH; Chou MH; Wu CL; Wei YC; Chen CH; Chuang JH
Mol Vis; 2012; 18():838-50. PubMed ID: 22511847
[TBL] [Abstract][Full Text] [Related]
24. HMGB1 Enhances the AGE-Induced Expression of CTGF and TGF-β via RAGE-Dependent Signaling in Renal Tubular Epithelial Cells.
Cheng M; Liu H; Zhang D; Liu Y; Wang C; Liu F; Chen J
Am J Nephrol; 2015; 41(3):257-66. PubMed ID: 25924590
[TBL] [Abstract][Full Text] [Related]
25. The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain.
Guo CH; Bai L; Wu HH; Yang J; Cai GH; Wang X; Wu SX; Ma W
Int J Mol Med; 2016 Nov; 38(5):1433-1442. PubMed ID: 28025994
[TBL] [Abstract][Full Text] [Related]
26. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages.
Kokkola R; Andersson A; Mullins G; Ostberg T; Treutiger CJ; Arnold B; Nawroth P; Andersson U; Harris RA; Harris HE
Scand J Immunol; 2005 Jan; 61(1):1-9. PubMed ID: 15644117
[TBL] [Abstract][Full Text] [Related]
27. [High mobility group box 1 is increased in children with acute lymphocytic leukemia and stimulates the release of tumor necrosis factor-alpha in leukemic cell].
Kang R; Tang DL; Cao LZ; Yu Y; Zhang GY; Xiao XZ
Zhonghua Er Ke Za Zhi; 2007 May; 45(5):329-33. PubMed ID: 17697615
[TBL] [Abstract][Full Text] [Related]
28. High-mobility group box-1 increases epithelial sodium channel activity and inflammation via the receptor for advanced glycation end products.
Grant GJ; Liou TG; Paine R; Helms MN
Am J Physiol Cell Physiol; 2020 Mar; 318(3):C570-C580. PubMed ID: 31913693
[TBL] [Abstract][Full Text] [Related]
29. Receptor for advanced glycation end products - membrane type1 matrix metalloproteinase axis regulates tissue factor expression via RhoA and Rac1 activation in high-mobility group box-1 stimulated endothelial cells.
Sugimoto K; Ohkawara H; Nakamura Y; Takuwa Y; Ishibashi T; Takeishi Y
PLoS One; 2014; 9(12):e114429. PubMed ID: 25490770
[TBL] [Abstract][Full Text] [Related]
30. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo.
van Zoelen MA; Yang H; Florquin S; Meijers JC; Akira S; Arnold B; Nawroth PP; Bierhaus A; Tracey KJ; van der Poll T
Shock; 2009 Mar; 31(3):280-4. PubMed ID: 19218854
[TBL] [Abstract][Full Text] [Related]
31. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products.
Qin YH; Dai SM; Tang GS; Zhang J; Ren D; Wang ZW; Shen Q
J Immunol; 2009 Nov; 183(10):6244-50. PubMed ID: 19890065
[TBL] [Abstract][Full Text] [Related]
32. High-mobility group box 1: a novel inducer of the epithelial-mesenchymal transition in colorectal carcinoma.
Zhu L; Li X; Chen Y; Fang J; Ge Z
Cancer Lett; 2015 Feb; 357(2):527-34. PubMed ID: 25511739
[TBL] [Abstract][Full Text] [Related]
33. Extracellular HSP70 Activates ERK1/2, NF-kB and Pro-Inflammatory Gene Transcription Through Binding with RAGE in A549 Human Lung Cancer Cells.
Somensi N; Brum PO; de Miranda Ramos V; Gasparotto J; Zanotto-Filho A; Rostirolla DC; da Silva Morrone M; Moreira JCF; Pens Gelain D
Cell Physiol Biochem; 2017; 42(6):2507-2522. PubMed ID: 28848092
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro.
Wang FC; Pei JX; Zhu J; Zhou NJ; Liu DS; Xiong HF; Liu XQ; Lin DJ; Xie Y
World J Gastroenterol; 2015 Jul; 21(25):7764-76. PubMed ID: 26167076
[TBL] [Abstract][Full Text] [Related]
35. IL-1β/HMGB1 signalling promotes the inflammatory cytokines release via TLR signalling in human intervertebral disc cells.
Fang F; Jiang D
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27512095
[TBL] [Abstract][Full Text] [Related]
36. [High mobility group box-1 protein activates endothelial cells to produce cytokines and has synergistic effect with lipopolysaccharide in inducing interleukin-6 release].
Liu JH; Li ZJ; Tang J; Liu YW; Zhao L; Deng P; Jiang Y
Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1191-5. PubMed ID: 16796861
[TBL] [Abstract][Full Text] [Related]
37. HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-α in human umbilical vein endothelial cells.
Luan ZG; Zhang H; Yang PT; Ma XC; Zhang C; Guo RX
Immunobiology; 2010 Dec; 215(12):956-62. PubMed ID: 20163887
[TBL] [Abstract][Full Text] [Related]
38. Production and application of HMGB1 derived recombinant RAGE-antagonist peptide for anti-inflammatory therapy in acute lung injury.
Lee S; Piao C; Kim G; Kim JY; Choi E; Lee M
Eur J Pharm Sci; 2018 Mar; 114():275-284. PubMed ID: 29292016
[TBL] [Abstract][Full Text] [Related]
39. Multi-walled carbon nanotube induces nitrative DNA damage in human lung epithelial cells via HMGB1-RAGE interaction and Toll-like receptor 9 activation.
Hiraku Y; Guo F; Ma N; Yamada T; Wang S; Kawanishi S; Murata M
Part Fibre Toxicol; 2016 Mar; 13():16. PubMed ID: 27026438
[TBL] [Abstract][Full Text] [Related]
40. HMGB1 promotes the synthesis of pro-IL-1β and pro-IL-18 by activation of p38 MAPK and NF-κB through receptors for advanced glycation end-products in macrophages.
He Q; You H; Li XM; Liu TH; Wang P; Wang BE
Asian Pac J Cancer Prev; 2012; 13(4):1365-70. PubMed ID: 22799333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
